Schmalbruch Ina K, Linde Rasmus, Paulson Olaf B, Madsen Peter L
Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Stroke. 2002 Jan;33(1):251-5. doi: 10.1161/hs0102.101233.
It has previously been shown that activation will increase cerebral blood flow (CBF) and cerebral glucose uptake (CMR(glc)) in excess of cerebral oxygen uptake (CMRO(2)). Our purpose was to investigate the influence of beta-adrenergic blockade with propranolol on the activation-induced uncoupling of cerebral glucose and oxygen metabolism.
Using awake rats, we determined the cerebral arteriovenous differences of oxygen [(a-v)(O2)], glucose [(a-v)(glc)], and lactate [(a-v)(lac)] both under baseline conditions and during activation. The molar ratio between CMRO(2) and CMR(glc), the oxygen-glucose index (OGI), was calculated.
Without beta-adrenergic blockade, activation decreased the (a-v)(O2) but not the (a-v)(glc), reducing the OGI from 6.1 during baseline conditions to 4.0 under activation (P<0.01). The (a-v)(O2) decreased, indicating that the ratio CBF/CMRO(2) had increased. Under baseline conditions, a slight flux of lactate from the brain was observed. Activation increased the arterial lactate concentration, and during this condition, the lactate flux from the brain was reversed into a slight lactate uptake. Propranolol administration did not change the behavior of the animals during activation. After administration of propranolol, baseline values were unaffected, but beta-adrenergic blockade totally abolished the activation-induced uncoupling of (a-v)(O2) from (a-v)(glc), because both remained constant with an unchanged OGI. The unchanged (a-v)(O2) indicates that CBF remained unchanged compared with CMRO(2).
beta-Adrenergic blockade by propranolol abolishes the activation-induced uncoupling of cerebral oxygen to glucose metabolism and the changes in (a-v)(O2). This may be of most significance to studies of cerebral activation by the blood oxygen level-dependent fMRI method.
先前的研究表明,激活会使脑血流量(CBF)和脑葡萄糖摄取量(CMR(glc))的增加超过脑氧摄取量(CMRO(2))。我们的目的是研究用普萘洛尔进行β-肾上腺素能阻滞对激活诱导的脑葡萄糖与氧代谢解偶联的影响。
使用清醒大鼠,我们测定了基线条件下以及激活期间氧[(a-v)(O2)]、葡萄糖[(a-v)(glc)]和乳酸[(a-v)(lac)]的脑动静脉差值。计算了CMRO(2)与CMR(glc)之间的摩尔比,即氧-葡萄糖指数(OGI)。
在无β-肾上腺素能阻滞的情况下,激活使(a-v)(O2)降低,但(a-v)(glc)未降低,OGI从基线条件下的6.1降至激活时的4.0(P<0.01)。(a-v)(O2)降低,表明CBF/CMRO(2)比值升高。在基线条件下,观察到有少量乳酸从脑内流出。激活增加了动脉血乳酸浓度,在此情况下,乳酸从脑内的流出转变为轻微的乳酸摄取。普萘洛尔给药并未改变动物在激活期间的行为。给予普萘洛尔后,基线值未受影响,但β-肾上腺素能阻滞完全消除了激活诱导的(a-v)(O2)与(a-v)(glc)之间的解偶联,因为二者均保持恒定,OGI不变。(a-v)(O2)不变表明与CMRO(2)相比CBF保持不变。
普萘洛尔进行的β-肾上腺素能阻滞消除了激活诱导的脑氧与葡萄糖代谢的解偶联以及(a-v)(O2)的变化。这对于采用血氧水平依赖性功能磁共振成像方法进行的脑激活研究可能具有重要意义。